Spotlight: The ‘new Thalidomide’ The PJ Pod podcast

Artwork

Science PJ Pod Pharmaceutical Journal

Indhold leveret af The PJ Pod and Pharmaceutical Journal. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af The PJ Pod and Pharmaceutical Journal eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

The PJ Pod « »
Spotlight: The ‘new thalidomide’

2y ago 9:12

Del

MP3•Episode hjem

Indhold leveret af The PJ Pod and Pharmaceutical Journal. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af The PJ Pod and Pharmaceutical Journal eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

In the UK, three babies are still being born each month after being exposed to sodium valproate. This is despite the risk of foetal valproate spectrum disorder being known about for many years. In the first of a series of shorter ‘Spotlight’ episodes, executive editor Nigel Praities speaks with senior data journalist, Julia Robinson, about her recent investigation into this issue and whether NHS England is on track to meet its target to reduce the use of the drug in people who can get pregnant by 50% by the end of 2023. Julia also gives an insight into new research that may suggest the risks from sodium valproate and other drugs used for epilepsy may have been underestimated. Click here to read the full investigation: https://pharmaceutical-journal.com/article/feature/why-is-the-uk-struggling-to-contain-its-sodium-valproate-problem This episode was produced by Geoff Marsh.

… continue reading

48 episoder

#Science #PJ Pod #Pharmaceutical Journal

Artwork

Spotlight: The ‘new thalidomide’

published 2y ago

Del

MP3•Episode hjem

Indhold leveret af The PJ Pod and Pharmaceutical Journal. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af The PJ Pod and Pharmaceutical Journal eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

In the UK, three babies are still being born each month after being exposed to sodium valproate. This is despite the risk of foetal valproate spectrum disorder being known about for many years. In the first of a series of shorter ‘Spotlight’ episodes, executive editor Nigel Praities speaks with senior data journalist, Julia Robinson, about her recent investigation into this issue and whether NHS England is on track to meet its target to reduce the use of the drug in people who can get pregnant by 50% by the end of 2023. Julia also gives an insight into new research that may suggest the risks from sodium valproate and other drugs used for epilepsy may have been underestimated. Click here to read the full investigation: https://pharmaceutical-journal.com/article/feature/why-is-the-uk-struggling-to-contain-its-sodium-valproate-problem This episode was produced by Geoff Marsh.

… continue reading

48 episoder

#Science #PJ Pod #Pharmaceutical Journal

Alle episoder

×

Velkommen til Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

Lyt til 500+ emner